Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5275992
Max Phase: Preclinical
Molecular Formula: C30H43ClO10
Molecular Weight: 599.12
Associated Items:
ID: ALA5275992
Max Phase: Preclinical
Molecular Formula: C30H43ClO10
Molecular Weight: 599.12
Associated Items:
Canonical SMILES: CO[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H](C[C@@]2(C)[C@H](C)CCC(=O)[C@@H]2C)/C(C)=C/Cc2c(O)c(Cl)c(C)c(C=O)c2O)O[C@@H]1CO
Standard InChI: InChI=1S/C30H43ClO10/c1-14(7-9-18-24(35)19(12-32)16(3)23(31)25(18)36)21(11-30(5)15(2)8-10-20(34)17(30)4)40-29-27(38)26(37)28(39-6)22(13-33)41-29/h7,12,15,17,21-22,26-29,33,35-38H,8-11,13H2,1-6H3/b14-7+/t15-,17+,21-,22-,26-,27-,28-,29-,30+/m1/s1
Standard InChI Key: QINPQFODEODUKM-USILLHITSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 599.12 | Molecular Weight (Monoisotopic): 598.2545 | AlogP: 3.23 | #Rotatable Bonds: 10 |
Polar Surface Area: 162.98 | Molecular Species: ACID | HBA: 10 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 5.84 | CX Basic pKa: | CX LogP: 4.66 | CX LogD: 3.17 |
Aromatic Rings: 1 | Heavy Atoms: 41 | QED Weighted: 0.20 | Np Likeness Score: 2.36 |
1. Govindarajan M.. (2018) Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics., 143 [PMID:29126728] [10.1016/j.ejmech.2017.10.015] |
Source(1):